Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.52 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.52 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 8/20 | 0.50 |
| ▸ | HTR2C | P28335 | 3/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | AXL | P30530 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30202128 | 0.91 | POLB (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL580565 | 0.91 | POLB (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL28799442 | 0.91 | POLB (0.61) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL298224 | 0.90 | POLB (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL3297985 | 0.84 | GRIN2D (0.45) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL10122740 | 0.84 | TSHR (0.47) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30081128 | 0.82 | AXL (0.53) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29815010 | 0.82 | GRIN2D (0.48) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL17913390 | 0.82 | AXL (0.53) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL28862709 | 0.82 | GRIN2D (0.48) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115232326-B | Metal organic framework material, preparation thereof and application thereof in electrode material | 吉林中科研伸科技有限公司 | 2023-02-14 | — | — | CN | claimed |
| CN-115232326-A | Metal organic framework material, preparation thereof and application thereof in electrode material | 吉林中科研伸科技有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-116023673-B | Preparation method of two-dimensional and three-dimensional clover-shaped metal organic supermolecule and metal organic cage | 黔南民族师范学院 | 2024-05-17 | — | — | CN | disclosed |
| US-11895917-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2024-02-06 | — | — | US | disclosed |
| CN-113845486-B | Anthracene-based macrocyclic molecule, and preparation method and application thereof | 南方科技大学 | 2023-09-26 | — | — | CN | disclosed |
| CN-115304615-B | Heterocyclic compound, organic electroluminescent device, and electronic device | 陕西莱特光电材料股份有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116023673-A | Preparation method of two-dimensional and three-dimensional clover-shaped metal organic supermolecule and metal organic cage | 黔南民族师范学院 | 2023-04-28 | — | — | CN | disclosed |
| CN-115232326-B | Metal organic framework material, preparation thereof and application thereof in electrode material | 吉林中科研伸科技有限公司 | 2023-02-14 | — | — | CN | disclosed |
| US-20220407018-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2022-12-22 | — | — | US | disclosed |
| CN-115385955-A | Tetrabiarylphosphine ligands and transition metal complexes thereof | 东莞市均成高新材料有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-115304615-A | Heterocyclic compound, organic electroluminescent element, and electronic device | 陕西莱特光电材料股份有限公司 | 2022-11-08 | — | — | CN | disclosed |
| WO-2009036161-A1 | PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2009-03-19 | — | — | WO | disclosed |
| US-20080125594-A1 | PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-05-29 | — | — | US | disclosed |
| US-20080125594-A1 | PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-05-29 | — | — | US | disclosed |
| WO-2008033836-A2 | PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2008-03-20 | — | — | WO | disclosed |
| US-4487934-A | Method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1984-12-11 | — | — | US | disclosed |
| EP-0041682-B1 | A METHOD OF PREPARING POLY-SUBSTITUTED ACYLBENZENES | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1983-09-21 | — | — | EP | disclosed |
| EP-0045478-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-02-10 | — | — | EP | disclosed |
| EP-0041682-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-12-16 | — | — | EP | disclosed |
| US-4304941-A | Method of preparing poly-substituted acylbenzenes | HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220407018-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | PPOX, EPCAM, STOM | GRIN2D 149/4885GRIN3B 1794/4885GRIN1 444/4885 |
| US-20080125594-A1 | PROCESS AND INTERMEDIATES FOR PREPARING INTEGRASE INHIBITORS | TYMS, TYMP, POLB | GRIN2D 3604/4885GRIN3B 3295/4885GRIN1 3983/4885 |
| US-11895917-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | PPOX, EPCAM, STOM | GRIN2D 149/4885GRIN3B 1794/4885GRIN1 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.